| Product Code: ETC8913013 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Qatar Parkinsons Disease Market Overview |
3.1 Qatar Country Macro Economic Indicators |
3.2 Qatar Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Qatar Parkinsons Disease Market - Industry Life Cycle |
3.4 Qatar Parkinsons Disease Market - Porter's Five Forces |
3.5 Qatar Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Qatar Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Qatar Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Qatar Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Qatar Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Qatar Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and understanding of Parkinson's disease among healthcare providers and patients in Qatar. |
4.2.2 Growing investment in healthcare infrastructure and facilities to improve diagnosis and treatment of Parkinson's disease. |
4.2.3 Rising geriatric population in Qatar, as Parkinson's disease is more prevalent among older individuals. |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals with expertise in managing Parkinson's disease. |
4.3.2 High cost associated with Parkinson's disease medications and treatments in Qatar, impacting access for some patients. |
4.3.3 Lack of comprehensive Parkinson's disease management programs and support services in the country. |
5 Qatar Parkinsons Disease Market Trends |
6 Qatar Parkinsons Disease Market, By Types |
6.1 Qatar Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Qatar Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Qatar Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Qatar Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Qatar Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Qatar Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Qatar Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Qatar Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Qatar Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Qatar Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Qatar Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Qatar Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Qatar Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Qatar Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Qatar Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Qatar Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Qatar Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Qatar Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Qatar Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Qatar Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Qatar Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Qatar Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Qatar Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Qatar Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Qatar Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Qatar Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Qatar Parkinsons Disease Market Export to Major Countries |
7.2 Qatar Parkinsons Disease Market Imports from Major Countries |
8 Qatar Parkinsons Disease Market Key Performance Indicators |
8.1 Average time from initial symptoms to diagnosis for Parkinson's disease patients in Qatar. |
8.2 Number of healthcare facilities offering specialized care and treatment for Parkinson's disease. |
8.3 Percentage of Parkinson's disease patients in Qatar receiving regular follow-up care and support services. |
9 Qatar Parkinsons Disease Market - Opportunity Assessment |
9.1 Qatar Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Qatar Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Qatar Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Qatar Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Qatar Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Qatar Parkinsons Disease Market - Competitive Landscape |
10.1 Qatar Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Qatar Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here